Pharmaceutical products

Tender description

Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. • etanercept, • Infliximab, • adalimumab, • methotrexate. The goods have been split into eight (8) categories, each of which are identified as a ‘Lot’. Full details of each lot are contained in section II.2) of this notice. Supply of Infliximab Subcutaneous to NHS Scotland. The authority has awarded this lot as a single supplier framework per line to one (1) framework participant. Supply of Adalimumab to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to five (5) framework participants. Supply of methotrexate (50 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) framework participants. Supply of methotrexate (50 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant. Supply of methotrexate (25 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant. Supply of methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant. Supply of Etanercept to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to three (3) framework participants. Supply of Infliximab IV to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to five (5) framework participants.